Youtopia Vitacura has completed a finance structuring
Youtopia Vitacura SpA. has raised funds to finance a new project.
Youtopia was born in 2015 with the opening of Youtopia Trapenses, a club that came to revolutionize the wellness industry in Chile. The added value that the company offers lies in its integral service with personalized plans, with access to fitness programs, swimming pool, studios, spa, therapy and deli, among others. The Youtopia group is comprised of three business units: Youtopia Holding, which develops and operates its own clubs and, in future, those of third parties; Youtopia Trapenses, a club that opened in 2015 and in 2019 had 1,850 members; and Youtopia Vitacura, a new project to be financed. The project was awarded a 40-year concession in 2019. It includes three stages: remodeling the club to be able to have 3,100 members, a new wellness clinic and the construction of 600 subway parking spaces. This will take place in the former Balthus Vitacura, located in the BordeRío sector.
Oaklins’ team in Chile acted as financial advisor to Youtopia to carry out the structuring of the financing of the three stages of the Youtopia Vitacura project.
Talk to the deal team
María de los Ángeles González Irarrázaval
Oaklins LarrainVial
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Learn more